SCHEMBL8353034

SCHEMBL8353034

CC(=O)NCC1(c2ccc(C)cc2)CCC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.58
CASP1 P29466 1/20 0.58
P2RX7 Q99572 3/20 0.48
LMNA P02545 3/20 0.48
MCHR1 Q99705 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
TP53 P04637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 2/20 0.45
MAPT P10636 2/20 0.44
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351482 0.97 TSHR (0.62) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL8353279 0.93 TSHR (0.54) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL8354195 0.86 MCHR1 (0.49) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL17888281 0.85 MCHR1 (0.65) TSHRCASP1P2RX7MCHR1
SCHEMBL14347866 0.84 TSHR (0.43) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL8351040 0.84 P2RX7 (0.55) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL8353957 0.83 SMN1; SMN2 (0.51) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL10576154 0.81 TSHR (0.59) TSHRCASP1LMNASMN1; SMN2L3MBTL1
SCHEMBL8351168 0.81 TSHR (0.46) TSHRCASP1P2RX7LMNAMCHR1
SCHEMBL3373766 0.81 LMNA (0.68) TSHRCASP1LMNASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed